Search Results - "Bourret, Jeffrey A"

Overview of alopecia areata for managed care and payer stakeholders in the United States by King, Brett, Pezalla, Edmund, Fung, Selwyn, Tran, Helen, Bourret, Jeffrey A, Peeples-Lamirande, Kathleen, Takiya, Liza, Napatalung, Lynne

“…Alopecia areata (AA) is an autoimmune disease with a complex pathophysiology resulting in nonscarring hair loss in genetically susceptible individuals. We aim…”
Get full text

The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives by Feldman, Steven R, Goffe, Bernard, Rice, Gary, Mitchell, Matthew, Kaur, Mandeep, Robertson, Debbie, Sierka, Debra, Bourret, Jeffrey A, Evans, Tamara S, Gottlieb, Alice

“…Psoriasis is a debilitating chronic inflammatory autoimmune disease affecting approximately 7.4 million adults in the United States. Plaque psoriasis is the…”
Get full text

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective by Claxton, Lindsay, Taylor, Matthew, Soonasra, Arif, Bourret, Jeffrey A, Gerber, Robert A

“…Treatment cycling with biologic disease-modifying anti-rheumatic drugs, such as tumor necrosis factor inhibitors (TNFi), is common among patients with…”
Get full text

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States by Claxton, Lindsay, Jenks, Michelle, Taylor, Matthew, Wallenstein, Gene, Mendelsohn, Alan M, Bourret, Jeffrey A, Singh, Amitabh, Moynagh, Dermot, Gerber, Robert A

“…Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib is approved in the United States for use in adults…”
Get full text

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry by Pappas, Dimitrios A, Gerber, Robert A, Litman, Heather J, Gruben, David, Geier, Jamie, Hua, Winnie D, Chen, Connie, Li, Youfu, Kremer, Joel M, Andrews, John S, Bourret, Jeffrey A

“…The implementation of treat-to-target principles in rheumatoid arthritis (RA) has not been fully investigated in patients with inadequate response to tumor…”
Get full text

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States by Claxton, Lindsay, Jenks, Michelle, Taylor, Matthew, Wallenstein, Gene, Mendelsohn, Alan M., Bourret, Jeffrey A., Singh, Amitabh, Moynagh, Dermot, Gerber, Robert A.

Get full text

Job characteristics and satisfaction of pharmacy technicians by Cortese, L M, Greenberger, D W, Schneider, P J, Bourret, J A

“…Perceptions of job characteristics and job satisfaction of central-area technicians and drug-administration technicians at The Ohio State University Hospitals…”
Get more information

Activity analysis of pharmacy-directed drug-administration technicians by Scala, S M, Schneider, P J, Smith, Jr, G L, Bourret, J A

“…The percentage of time required by drug-administration technicians to perform predefined activities was determined using a work-sampling technique. Two trained…”
Get more information

Costs of training drug-administration technicians by Fillmore, A D, Schneider, P J, Bourret, J A, Caswell, R J

“…The costs associated with training drug-administration pharmacy technicians in a 1000-bed university teaching hospital were determined. Data were collected…”
Get more information

Cost justifying a pharmacy residency program by Schneider, P J, Boman, D M, Bourret, J A, Ngu, B Q, Ouellette, S M, Smeek, D M

“…Cost justification of a pharmacy residency training program was prepared. The contributions of the pharmacy residents were tabulated and compared with the cost…”
Get more information